^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    JBJ-08–178–01

    i
    Other names: JBJ-08–178–01

    Associations

    News
    Trials
    Company:
    Dana-Farber Cancer Institute, Stanford University
    Drug class:
    HER2 inhibitor
    Related drugs:

    Associations

    News
    Trials